
Initial patient dosed in Phase 2a clinical trial evaluating first-in-class human milk-based therapy
In a breakthrough for human milk science, researchers at City of Hope, Los Angeles, have dosed the first patient in a Phase 2a clinical trial evaluating a novel therapy for blood cancer patients undergoing allogeneic […]